| 2025-05-13 | 10-Q | 10.1 | Second Amended and Restated Executive Employment Agreement, by and between the Company and Sandeep Laumas, M.D. dated as of May 12, 2025. |
|---|
| 2025-03-04 | 10-K | 10.14 | Recourse Indemnity Agreement, by and between the Registrant and Midland National Life Insurance Company, dated December 22, 2024. |
|---|
| 2025-03-04 | 10-K | 10.13 | Term Loan Agreement, by and between Complex Therapeutics LLC and Midland National Life Insurance Company, dated December 20, 2024. |
|---|
| 2024-08-13 | 10-Q | 10.4 | License and Collaboration Agreement dated August 1, 2024 by and between ImmuneOnco Biopharmaceuticals (Shanghai) Inc. and SynBioTx, Inc. |
|---|
| 2024-08-13 | 10-Q | 10.3 | Lease dated July 10, 2024 by and between Complex Therapeutics LLC and AstraZeneca Pharmaceuticals LP. |
|---|
| 2024-08-13 | 10-Q | 10.2 | First Amendment to Mezzanine Loan Agreement and Omnibus Amendment to Mezzanine Loan Documents dated July 10, 2024 by and among OP USA Debt Holdings II Limited Partnership, Complex Therapeutics Mezzanine LLC and Instil Bio, Inc. |
|---|
| 2024-08-13 | 10-Q | 10.1 | First Amendment to Loan Agreement and Omnibus Amendment to Loan Documents dated July 10, 2024 by and among OP USA Debt Holdings II Limited Partnership, Complex Therapeutics LLC and Instil Bio, Inc. |
|---|
| 2024-05-10 | 10-Q | 10.2 | Retention Bonus Agreement, by and between the Registrant and Sandeep Laumas, M.D. dated as of February 12, 2024 |
|---|
| 2024-05-10 | 10-Q | 10.1 | Retention Bonus Agreement, by and between the Registrant and Bronson Crouch, dated as of February 12, 2024 |
|---|
| 2024-03-21 | 10-K | 10.6 | Amended and Restated Non-Employee Director Compensation Policy |
|---|
| 2024-02-14 | 8-K | 10.1 | Form of Retention Bonus Agreement. |
|---|
| 2023-08-14 | 10-Q | 10.1 | Separation Agreement, by and between the Registrant and Sumita Ray, dated as of April 14, 2023. |
|---|
| 2023-05-11 | 10-Q | 10.2 | Retention Bonus Agreement, by and between the Registrant and Sandeep Laumas, M.D. dated as of February 22, 2023 |
|---|
| 2023-05-11 | 10-Q | 10.1 | Retention Bonus Agreement, by and between the Registrant and Bronson Crouch, dated as of February 22, 2023 |
|---|
| 2023-03-31 | 10-K | 10.12 | Separation Agreement, by and between the Registrant and Zachary Roberts, M.D., Ph.D., dated as of November 11, 2022. |
|---|
| 2023-03-31 | 10-K | 10.11 | Separation Agreement, by and between the Registrant and Timothy L. Moore, dated as of December 8, 2022. |
|---|
| 2023-03-31 | 10-K | 10.9 | Executive Employment Agreement, by and between the Registrant and Sumita Ray, dated as of April 18, 2022. |
|---|
| 2023-03-31 | 10-K | 10.6 | Non-Employee Director Compensation Policy |
|---|
| 2023-02-27 | 8-K | 10.1 | Form of Retention Bonus Agreement. |
|---|
| 2022-11-14 | 10-Q | 10.1 | Employment Agreement, by and between the Registrant and Timothy L. Moore, dated as of September 6, 2022. |
|---|
| 2022-08-12 | 10-Q | 10.2 | Mezzanine Loan Agreement, by and between Complex Therapeutics Mezzanine LLC and OPG Hermes Investments (DE) LLC, dated June 10, 2022. |
|---|
| 2022-08-12 | 10-Q | 10.1 | Loan Agreement, by and between Complex Therapeutics LLC and OPG Hermes Investments (DE) LLC, dated June 10, 2022. |
|---|
| 2022-05-16 | 10-Q | 10.1 | Executive Employment Agreement by and between the Company and Vijay Chiruvolu effective as of July 17, 2021. |
|---|